Biotechnology and Pharmaceuticals

January 15, 2016

Companies covered: Gilead Sciences, Inc. (NASDAQ:GILD), Intra-Cellular Therapies Inc. (NASDAQ:ITCI), Cempra, Inc. (NASDAQ:CEMP), Achaogen, Inc. (NASDAQ:AKAO), Wave Life Sciences Ltd (NASDAQ:WVE), Intrexon Corporation (NYSE:XON), Johnson & Johnson (NYSE:JNJ), Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA), ZIOPHARM Oncology Inc (NASDAQ:ZIOP), Fibrocell Science Inc (NASDAQ:FCSC), Synthetic Biologics, Inc (NYSEMKT:SYN), Juno Therapeutics, Inc. (NASDAQ:JUNO), Kite Pharma, Inc. (NASDAQ:KITE), Lightlake Therapeutics (OTCMKTS:LLTP), Cynapsus Therapeutics Inc (NASDAQ:CYNA), Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), Bio-Path Holdings, Inc. (NASDAQ:BPTH)

Buy ($175)

Pets & Vets

November 27, 2015

Companies covered: Zoetis Inc. (NYSE:ZTS), IDEXX Laboratories, Inc. (NASDAQ:IDXX), ABAXIS, Inc. (NASDAQ:ABAX), Henry Schein, Inc. (NASDAQ:HSIC), Patterson Companies, Inc. (NASDAQ:PDCO), AmerisourceBergen Corporation (Holding Co) (NYSE:ABC), VCA Inc. (NASDAQ:WOOF), PetMed Express, Inc. (NASDAQ:PETS), Aratana Therapeutics, Inc. (NASDAQ:PETX), Nexvet Biopharma plc (NASDAQ:NVET), Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), Yamaha Motor Co., Ltd. (TYO:7272), Jaguar Animal Health Inc (NASDAQ:JAGX), Phibro Animal Health Corporation (NASDAQ:PAHC), Kindred Biosciences, Inc. (NASDAQ:KIN), Trupanion, Inc. (NYSE:TRUP), Virbac SA (EPA:VIRP), Vetoquinol SA (EPA:VETO), Blue Buffalo Pet Products Inc (NASDAQ:BUFF), Freshpet, Inc. (NASDAQ:FRPT), Sanofi (NYSE:SNY), Merck & Company, Inc. (NYSE:MRK), Where Food Comes From, Inc. (OTCMKTS:WFCF), Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI), Eli Lilly and Company (NYSE:LLY), Novartis AG (NYSE:NVS), Cardinal Health, Inc. (NYSE:CAH), McKesson Corporation (NYSE:MCK), Pfizer, Inc. (NYSE:PFE), CVS Health Corporation (NYSE:CVS), Intersections, Inc. (NASDAQ:INTX)

Buy ($175)

Medical Research, Diagnostic Substances & Life Science Tools

October 23, 2015

Companies covered: Abbott Laboratories (NYSE:ABT), Illumina, Inc. (NASDAQ:ILMN), Alere Inc. (NYSE:ALR), Agilent Technologies, Inc. (NYSE:A), Bruker Corporation (NASDAQ:BRKR), Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corporation (NYSE:DHR), NanoString Technologies, Inc. (NASDAQ:NSTG), Genomic Health, Inc. (NASDAQ:GHDX), Stryker Corporation (NYSE:SYK), Teleflex Incorporated (NYSE:TFX), Zimmer Holdings, Inc. (NYSE:ZMH), Smith & Nephew SNATS, Inc. (NYSE:SNN), NuVasive, Inc. (NASDAQ:NUVA), Globus Medical, Inc. (NYSE:GMED), Accuray Incorporated (NASDAQ:ARAY), Medtronic, Inc. (NYSE:MDT), Varian Medical Systems, Inc. (NYSE:VAR), LeMaitre Vascular, Inc. (NASDAQ:LMAT), MiMedx Group, Inc (NASDAQ:MDXG), Johnson & Johnson (NYSE:JNJ), EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), Soligenix, Inc. (OTCBB:SNGX), Protea Biosciences Group, Inc. (OTCBB:PRGB), AmpliPhi Biosciences Corporation (NYSEMKT:APHB), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), CombiMatrix Corporation (NASDAQ:CBMX), DBV Technologies S.A. (NASDAQ:DBVT), Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), United Cannabis Corporation (OTCBB:CNAB)

Buy ($175)

Biotechnology and Pharmaceuticals

August 14, 2015

Topics covered: Value Investing in Biotech and Pharmaceuticals, Regenerative Medicine, Ophthalmic Pharmaceuticals, Gene Therapies, Duchenne Muscular Dystrophy Treatments, Drugs for Liver Disease, Cancer Immunotherapy

Companies covered: Applied Genetic Technologies Corporation (NASDAQ:AGTC), Celgene Corporation (NASDAQ:CELG), Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI), bluebird bio, Inc. (NASDAQ:BLUE), Athersys, Inc. (NASDAQ:ATHX), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Agenus Inc. (NASDAQ:AGEN), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Pfizer, Inc. (NYSE:PFE), Opexa Therapeutics, Inc. (NASDAQ:OPXA), Mylan Inc. (NASDAQ:MYL), Medivation, Inc. (NASDAQ:MDVN), Eli Lilly and Company (NYSE:LLY), Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Gilead Sciences, Inc. (NASDAQ:GILD), Mast Therapeutics, Inc. (AMEX:MSTX)

Buy ($175)

Medical Devices

July 31, 2015

Topics covered: Women's Health, Strong Underlying Fundamentals, Peripheral Vascular Medical Devices, Imaging in Oncology, Differentiated Technological Platforms, Cardiovascular Medical Devices, A Focus on Quality

Companies covered: Thoratec Corporation (NASDAQ:THOR), St. Jude Medical, Inc. (NYSE:STJ), The Spectranetics Corporation (NASDAQ:SPNC), Medtronic, Inc. (NYSE:MDT), Heartware International, Inc. (NASDAQ:HTWR), Edwards Lifesciences Corporation (NYSE:EW), Covidien Ltd. (NYSE:COV), Boston Scientific Corporation (NYSE:BSX), VirtualScopics, Inc. (NASDAQ:VSCP)

Buy ($175)

Pin It on Pinterest